Matthew R. Warr

3.9k total citations · 2 hit papers
30 papers, 2.9k citations indexed

About

Matthew R. Warr is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Matthew R. Warr has authored 30 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Matthew R. Warr's work include Congenital Heart Disease Studies (5 papers), Acute Myeloid Leukemia Research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Matthew R. Warr is often cited by papers focused on Congenital Heart Disease Studies (5 papers), Acute Myeloid Leukemia Research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Matthew R. Warr collaborates with scholars based in United States, Canada and Austria. Matthew R. Warr's co-authors include Emmanuelle Passegué, Johanna Flach, Eric M. Pietras, Gordon C. Shore, Theodore Ho, Evgenia Verovskaya, María E. Figueroa, Emmalee R. Adelman, Olivia Lansinger and Mikhail Binnewies and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Matthew R. Warr

28 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy maintains the metabolism and function of young and old stem cells

2017 641 citations Matthew R. Warr, Johanna Flach et al. Nature profile →
FOXO3A directs a protective autophagy program in haematopoietic stem cells

2013 473 citations Matthew R. Warr, Mikhail Binnewies et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew R. Warr United States	17	1.6k	876	748	477	454	30	2.9k
Takashi Murate Japan	32	2.0k 1.2×	944 1.1×	245 0.3×	426 0.9×	504 1.1×	137	3.5k
Karlheinz Holzmann Germany	32	1.6k 1.0×	425 0.5×	278 0.4×	575 1.2×	406 0.9×	83	3.4k
Kamil R. Kranc United Kingdom	20	1.2k 0.7×	479 0.5×	441 0.6×	446 0.9×	187 0.4×	41	2.1k
Jan Jacob Schuringa Netherlands	39	2.1k 1.3×	1.8k 2.1×	253 0.3×	918 1.9×	581 1.3×	147	4.1k
Soichi Sano Japan	19	1.2k 0.7×	565 0.6×	224 0.3×	554 1.2×	381 0.8×	52	2.3k
Samirkumar B. Amin United States	18	1.3k 0.8×	503 0.6×	267 0.4×	260 0.5×	162 0.4×	43	2.3k
Véronique Mansat‐De Mas France	25	1.3k 0.8×	1.4k 1.6×	157 0.2×	358 0.8×	546 1.2×	57	2.5k
Hui Yang United States	35	2.7k 1.7×	1.8k 2.0×	196 0.3×	623 1.3×	535 1.2×	135	4.1k
David J. Shields United States	23	1.7k 1.1×	520 0.6×	171 0.2×	315 0.7×	275 0.6×	44	3.2k
Emma C. Josefsson Australia	29	1.2k 0.7×	1.6k 1.8×	132 0.2×	647 1.4×	332 0.7×	61	3.0k

Countries citing papers authored by Matthew R. Warr

Since Specialization

Citations

This map shows the geographic impact of Matthew R. Warr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Warr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Warr more than expected).

Fields of papers citing papers by Matthew R. Warr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Warr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Warr. The network helps show where Matthew R. Warr may publish in the future.

Co-authorship network of co-authors of Matthew R. Warr

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Warr. A scholar is included among the top collaborators of Matthew R. Warr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Warr. Matthew R. Warr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ammann, Stephen E., Ryan Ferrao, Pia Mukherjee, et al.. (2025). Examination of Noncanonical Kinase Hinge Binders Leads to Thiadiazoles as Potent IRAK4 Inhibitors. ACS Medicinal Chemistry Letters. 17(1). 175–182.

Kang, Yoon-A, Si Yi Zhang, Oakley C. Olson, et al.. (2023). Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production. The Journal of Experimental Medicine. 220(8). 9 indexed citations

Zheng, Jim, Xin Yan, Jingyu Zhang, et al.. (2018). Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development. Drug Metabolism and Disposition. 46(3). 237–247. 40 indexed citations

Aßhoff, Malte, Verena Petzer, Matthew R. Warr, et al.. (2017). Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents. Blood. 129(13). 1823–1830. 156 indexed citations

Chan, Andrew, Stewart Clegg, & Matthew R. Warr. (2017). Translating Intervention: When Corporate Culture Meets Chinese Socialism. Journal of Management Inquiry. 27(2). 190–203. 4 indexed citations

Warr, Matthew R., Malte Aßhoff, Jim Zheng, et al.. (2016). Preclinical Modeling of ACVR1-Dependent Hepcidin Production and Anemia By Momelotinib. Blood. 128(22). 1967–1967. 3 indexed citations

Ugarte, Fernando, Bertrand Cinquin, Eric W. Martin, et al.. (2015). Progressive Chromatin Condensation and H3K9 Methylation Regulate the Differentiation of Embryonic and Hematopoietic Stem Cells. Stem Cell Reports. 5(5). 728–740. 88 indexed citations

Warr, Matthew R., Mikhail Binnewies, Johanna Flach, et al.. (2013). FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature. 494(7437). 323–327. 473 indexed citations breakdown →

Warr, Matthew R., John R. Mills, Mai Nguyen, et al.. (2011). Mitochondrion-dependent N-terminal Processing of Outer Membrane Mcl-1 Protein Removes an Essential Mule/Lasu1 Protein-binding Site. Journal of Biological Chemistry. 286(28). 25098–25107. 26 indexed citations

10.

Garcia, Daniel, Matthew R. Warr, Carla P. Martins, et al.. (2011). Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes & Development. 25(16). 1746–1757. 69 indexed citations

11.

Pietras, Eric M., Matthew R. Warr, & Emmanuelle Passegué. (2011). Cell cycle regulation in hematopoietic stem cells. The Journal of Experimental Medicine. 208(13). i34–i34. 5 indexed citations

12.

Warr, Matthew R., Mai Nguyen, & Gordon C. Shore. (2011). Response to Yang-Yen: Does N-terminal Processing of Mcl-1 Occur at Mitochondrial Outer Membrane or Matrix?. Journal of Biological Chemistry. 286(30). le16–le16. 1 indexed citations

13.

Shore, Gordon C. & Matthew R. Warr. (2008). Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer. Current Molecular Medicine. 8(2). 138–147. 158 indexed citations

14.

Warr, Matthew R. & G C Shore. (2008). Small-Molecule Bcl-2 Antagonists as Targeted Therapy in Oncology. Current Oncology. 15(6). 256–261. 20 indexed citations

15.

Swan, Lorna, C. Varma, James Yip, et al.. (2005). Transcatheter device closure of atrial septal defects in the elderly: Technical considerations and short-term outcomes. International Journal of Cardiology. 107(2). 207–210. 37 indexed citations

16.

Warr, Matthew R., Stéphane Acoca, Zhiqian Liu, et al.. (2005). BH3‐ligand regulates access of MCL‐1 to its E3 ligase. FEBS Letters. 579(25). 5603–5608. 96 indexed citations

17.

Varma, Chetan, Lee Benson, Matthew R. Warr, et al.. (2004). Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance. Catheterization and Cardiovascular Interventions. 62(4). 519–525. 25 indexed citations

18.

Varma, Chetan, Matthew R. Warr, Aaron Hendler, et al.. (2003). Prevalence of silent pulmonary emboli in adults after the Fontan operation. Journal of the American College of Cardiology. 41(6). 487–487. 6 indexed citations

19.

Swan, Lorna, Chetan Varma, James Yip, et al.. (2003). Favorable right heart remodeling after atrial septal defect device closure even in the over-60 age group. Journal of the American College of Cardiology. 41(6). 473–473. 3 indexed citations

20.

Varma, Chetan, Matthew R. Warr, Aaron Hendler, et al.. (2003). Prevalence of “silent” pulmonary emboli in adults after the Fontan operation. Journal of the American College of Cardiology. 41(12). 2252–2258. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact